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a b s t r a c t
Background and purpose: Measurement of either ﬂow-mediated endothelium-dependent dilatation
(FMD) of the brachial artery, brachial-ankle pulse wave velocity (baPWV), or intima-media thickness
(IMT) of the carotid artery is useful for risk assessment of future cardiovascular events. This study exam-
ined whether combination of these vascular parameters may have an additive effect on the ability of
traditional risk factors to predict coronary events in patients with chronic coronary artery disease (CAD).
Methods: Patients (n=923) with stable CAD had measurements of FMD, baPWV, and maximum IMT
(maxIMT), and were prospectively followed up for <8.5 years or until a coronary event – cardiac death,
non-fatal myocardial infarction (MI) or unstable angina pectoris (uAP) requiring unplanned coronary
revascularization.
Results:During the follow-upperiod, 116eventsoccurred (29cardiacdeaths, 46non-fatalMIsand41cases
of uAP). A multivariate Cox proportional hazards analysis showed that FMD (HR 0.50, 95% CI 0.38–0.66)
and baPWV (HR 1.52, 95% CI 1.27–1.82) but not maxIMT were signiﬁcant predictors of coronary events.
Basedon the concordance statistics, the predictive value of traditional risk factors [area under the receiver
operating characteristic curve (AUC), 0.67] was increased more by the addition of FMD and baPWV com-
bined (AUC,0.75) comparedwith theadditionof eithermaxIMT, FMD,orbaPWValone, or thecombination
of maxIMT and FMD or maxIMT and baPWV (AUC, 0.67, 0.71, 0.71, 0.71 and 0.71, respectively).
Conclusions: The combined addition of FMD and baPWV to the risk assessment algorithms may be useful
for risk stratiﬁcation of chronic CAD patients.
4 Jap© 201
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Non-invasive vascular function tests are widely used and have
een shown to be useful to assess the risk of future cardio-
ascular (CV) events [1–14]. The relevant vascular tests include
ow-mediated dilation (FMD) of the brachial artery to assess
ndothelial function, pulse wave velocity (PWV) to assess arterial
tiffness, and intima-media thickness (IMT) of the carotid artery to
ssess atherosclerotic plaque burden and/or medial hypertrophy
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amanashi, Faculty of Medicine, 1110 Shimokato, Chuo 409-3898, Japan.
el.: +81 55 273 9590; fax: +81 55 273 6749.
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914-5087/$ – see front matter © 2014 Japanese College of Cardiology. Published by Else
ttp://dx.doi.org/10.1016/j.jjcc.2014.01.004anese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
[1–14]. These vascular parameters predicted CV events [1,4–14],
and the addition of each of these vascular parameters had a signif-
icant incremental effect on the ability of traditional risk factors to
predict future CV events [9,10,12–14]. In general, the clustering of
traditional risk factors increases the likelihood of future CV events
[15,16]. However, it remains unknown whether the combination
of these vascular parameters may also have additive effects on the
ability of traditional risk factors to predict future CV events. More-
over, it remains unknown which combination among PWV, FMD,
and IMT has the greatest predictive value for CV events.
These vascular parameters are not necessarily correlated with
each other [17–20], and their correlation depends on the types of
patients that are evaluated [17–20]. When these vascular param-
eters have no correlation, they may reﬂect different aspects of
arterial structural or functional impairment in the study patients.
vier Ltd. All rights reserved.
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n this case, the combination of these vascular tests could have
dditive value for risk assessment. However, it remains unclear
hether these vascular parameters are correlated with each other
n patients with coronary artery disease (CAD) and high CV risk.
hus, we assessed FMD of the brachial artery, brachial-ankle PWV
baPWV), and IMT of the carotid artery in patients with chronic
AD, and tested the hypothesis that combined assessment of these
ascular parameters may have an additive effect on the ability of
raditional risk factors to predict future coronary events in patients
ith chronic CAD.
ethods
tudy patients
This study screened 1553 consecutively enrolled patients with
table CAD at the cardiology section of Yamanashi University Hos-
ital from January 1, 2002 to March 31, 2010. All the patients had
outine non-invasive vascular measurements including FMD of the
rachial artery, baPWV, and IMT of the carotid artery. The inclu-
ion criteria were: (1) stable CAD with an organic stenosis of >70%
f at least one major coronary artery or previous coronary revas-
ularization; (2) no episode of angina at rest and no changes in
he frequency of angina in response to sublingual nitroglycerin in
he previous 3 months. Exclusion criteria were: (1) acute coronary
yndrome, stroke, cardiogenic shock, pulmonary edema, major
urgery, trauma or serious infectious disease within 4 weeks prior
o enrollment; (2) neoplasm, signiﬁcant hepatic or inﬂammatory
isease; (3) chronic renal failure or serum creatinine >2.5mg/dL,
ongestive heart failure, or left main coronary trunk disease; or (4)
ther serious diseases. This study ﬁnally enrolled 940 patients who
et all of the inclusion and exclusion criteria. The baseline charac-
eristics of the patients are summarized in Table 1. All the patients
ave written, informed consent for the study at enrollment. The
tudy was conducted in agreement with guidelines approved by
he ethics committee of Yamanashi University Hospital.
able 1
aseline characteristics of the patients.
Total patients (n=923) P
Age (years) 65±12 6
Male gender, n (%) 660 (72) 8
Hypertension, n (%) 551 (60) 8
Current smoking, n (%) 513 (56) 6
Diabetes mellitus, n (%) 311 (34) 5
History of ACS, n (%) 304 (33) 4
LDL-C (mg/dL) 118 (95, 140) 1
HDL-C (mg/dL) 46 (38, 56) 4
Triglyceride (mg/dL) 124 (92, 171) 1
Multivessel CAD, n (%) 379 (41) 7
Systolic BP (mmHg) 139±27 1
LVEF (%) 60.6±13.3 5
CRP (mg/dL) 0.23 (0.06, 0.32) 0
BMI (kg/m2) 23.7±3.3 2
maxIMT (mm) 0.9 (1.4, 2.2) 0
baPWV (cm/s) 1651±381 1
FMD (%) 6.1±3.1 4
Medication, n (%)
Aspirin 728 (79) 1
Statin 303 (32) 3
ACEI/ARB 471 (51) 7
Beta blocker 151 (16) 2
ata are expressed either as themean value± SD,median and range (25 and 75th percentil
ipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; CAD, coronary artery
eptide; BMI, body mass index; ACEI, angiotensin-converting enzyme inhibitor; ARB, ang
rachial-ankle pulse wave velocity; FMD, ﬂow-mediated vasodilatation of the brachial ar
* p<0.05 vs. patients with events.diology 64 (2014) 179–184
Follow-up study
After the baseline data including the vascular parameters had
been obtained at our hospital, the 940 patients were followed-
up prospectively every 2 months at a hospital by the patients’
primary physicians for a period of <102 months, or until the occur-
rence of a coronary event that included cardiac death, non-fatal
myocardial infarction (MI), or refractory unstable angina pectoris
(uAP) requiring unplanned coronary revascularization. The time to
the ﬁrst event was evaluated prospectively. Cardiac deaths were
deﬁned as sudden cardiac death or pump failure death. Acute MI
and uAP were diagnosed by the presence of acute ischemic symp-
toms lasting ≥20min within 48h before admission to the hospital,
and electrocardiographic changes. Acute MI was diagnosed when
creatine kinase-MB levels increased by at least 2 times the upper
limit of normal or when troponin T levels were >0.1ng/mL. The
diagnosis of MI and uAP was conﬁrmed by coronary angiography.
Medical therapies for the enrolled study patients are outlined in
Table 1.
The follow-up data were obtained every three months from the
patients’ primary physicians and then collated by the investiga-
tors (K.K., Y.K.), who were blinded to the patient characteristics
at enrollment. All endpoint data were checked strictly for accu-
racy, consistency, and completeness of follow-up by the other
investigators (D.F., Y.S.), who also had no knowledge of the base-
line characteristics. Additional information was obtained from the
physicians as required. Two of the investigators (W.S., T.N.) were
responsible for checking all the data, carrying out the analyses, and
maintaining security of the data ﬁles.
Measurement of ﬂow-mediated dilation in the brachial artery
Vasodilator responses in the brachial arteries were measured
using B-mode ultrasound images with a 7.5-MHz linear array
transducer (HP-5500, Phillips Corp., Tokyo, Japan) according to
our previously validated method [8,9]. The brachial artery was
scanned in the antecubital fossa in a longitudinal fashion. After
atients with events (n=116) Patients without events (n=807)
7±11 65±12*
6 (74) 574 (71)
7 (75) 464 (57)
5 (56) 448 (55)
9 (51) 252 (31)*
5 (39) 259 (32)
22 (98, 145) 110 (90, 130)*
3 (37, 54) 47 (38, 57)
32 (96, 168) 123 (92, 172)
8 (58) 301 (38)*
38±27 136±28
9.9±13.9 60.7±13.3
.24 (0.06, 0.33) 0.20 (0.05, 0.30)
3.6±3.4 23.7±3.3
.95 (1.5, 2.6) 0.9 (1.4, 2.1)*
833±378 1625±375*
.2±3.4 6.3±3.6*
18 (88) 610 (77)
8 (29) 265 (33)
6 (56) 395 (50)
7 (20) 124 (15)
e), or as number (%) of patients. ACS, acute coronary syndrome;HDL-C, high-density
disease; BP, blood pressure; LVEF, left ventricular ejection fraction; CRP, C-reactive
iotensin II receptor blocker; maxIMT, maximum intima-media thickness; baPWV,
tery.
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aseline measurements of the diameter and ﬂow velocity in the
rachial artery, a blood pressure cuff was placed around the fore-
rmand inﬂated toapressureof250–300mmHgfor5min, and then
eleased. Diametermeasurements during reactive hyperemiawere
aken 45–90 s after cuff deﬂation. The changes in vessel diameter
n response to reactive hyperemia (FMD) were expressed as a per-
entage increase in diameter from the baseline value. The diameter
esponses were assessed at three locations along a 10-mm length
f the artery, and the results averaged for use in the statistical anal-
ses. In our studies, the repeated measurement of baseline arterial
iameter had an interobserver variability of 0.04±0.01mm, and
n intraobserver variability of 0.02±0.01mm. When these studies
ere performed at the same time on 2 separate days in 20 control
ubjects, the difference in arterial diameter during reactive hyper-
mia between the two days in each subject was 0.05±0.01mm,
ielding a mean difference of 1.1±1.0% of FMD.
easurement of brachial-ankle pulse wave velocity
The measurement of baPWV is easy to perform and this param-
ter is closely correlated with aortic PWV and carotid-femoral
WV [21,22]. We measured baPWV by a volume plethysmographic
ethod using automatic waveform analyzer (VP-1000; Colin Co.
td., Komaki, Japan), according to the manufacturer’s instructions
21,22]. Before measurements, patients were required to be in the
upine position and rest for at least 5min. Cuffs were wrapped
round both upper arms and ankles. Phonogram, pulse volume
aveform, blood pressure, and heart rate were recorded simulta-
eously. baPWVwas calculated bymeasuring the time for the pulse
ave to travel between the brachial and posterior tibial arteries.
he mean value of the left and right baPWV was used in the sta-
istical analyses. All measurements were performed by the same
xperienced operators blinded to patients’ baseline characteris-
ics (K.W., M.U.). The inter- and intra-observer variability for the
epeated measurements of baPWV in 30 patients on separate days
ere 62±31 cm/s and 53±26 cm/s, respectively.
arotid ultrasound evaluation
A carotid ultrasound examinationwas performed using an 11.0-
Hz, linear-array transducer (SONOS-5500, Phillips, Andover, MA,
SA) [6,9,23]. Two well-trained researchers (W.S., J.O.) performed
ll the carotid scans without any information on the clinical char-
cteristics of the patients. Each common, bifurcation, and internal
arotidarterywas imaged in theanterioroblique, lateral, andposte-
ior oblique planes to identify atherosclerotic lesions. Longitudinal
mages of each carotid artery were used to measure IMT, deﬁned as
he distance from the leading edge of the lumen-intima interface
o the leading edge of the media–adventitia interface. The IMT of
laques (>1.1mm)wasalso included.MaximumIMT (maxIMT)was
eﬁned as the greatest IMT in the 6 carotid arteries including the
ommon carotid artery, the bifurcation, and the proximal internal
arotid artery of right and left sides. In our studies, the mean biases
f the inter- and intra-observer for the repeated measurements of
axIMT in 20 patients extracted at random were 0.02±0.24mm
nd 0.01±0.17mm, respectively.
aboratory examinations
At the time of enrollment into the study, venous blood samples
ere obtained fromall patients after a 12-h overnight fast. Levels of
otal cholesterol (TC), high-density lipoprotein cholesterol (HDL-C),
nd low-density lipoprotein cholesterol (LDL-C) in fasting serum
ere measured as described previously [8,9]. C-reactive proteindiology 64 (2014) 179–184 181
(CRP) levels in fasting plasma were assayed by rate nephelometry
(Dade Behring, Marburg, Germany).
Statistical analysis
All descriptive data are expressed as either the mean± SD,
medianand range (25thand75thpercentile) or frequencies (%). The
Shapiro–Wilk test showed that the levels of LDL-C, HDL-C, triglyc-
eride, CRP, and maxIMT were not normally distributed. Therefore,
these data were expressed as the median and interquartile range
(25–75th percentiles) and were log-transformed for statistical
analysis. Themeanvalues and frequencieswere comparedbetween
the two groups using an unpaired t-test and Chi-square analy-
sis, respectively. Correlation of vascular parameters was examined
using linear regression analysis. The predictive values of FMD,
baPWV, IMT, and the other clinical variables were assessed by uni-
variate and multivariate Cox proportional hazards analysis. The
multivariate Cox proportional hazards analysis was performed
using variables that were signiﬁcant in the univariate model. In
both the univariate and multivariate Cox models, the predictive
values of the continuous variables were assessed by using 1-SD
increments. The dichotomous variables were coded as 1 or 0 for
the presence or absence of a factor, respectively. The number of
diseasedvesselswas codedas1, 2, or 3, for single-, double- or triple-
vessel disease, respectively. TheCoxmodels includedonlyvariables
that showed proportionality in a Schoenfeld residuals test.
We used the concordance (C) statistics that incorporated
receiver operating characteristic (ROC) curve analysis to examine
the incremental effects of the vascular parameters on the pre-
dictive value of our baseline model of known risk factors that
included age, male gender, LDL-C levels, systolic blood pressure,
number of diseased vessels, smoking, and diabetes mellitus. The
Hosmer–Lemeshow goodness-of-ﬁt test was used to assess the ﬁt
of the logistic model.
Wealso assessed thenet reclassiﬁcation improvement (NRI) and
integrated discrimination improvement (IDI) to analyze the pre-
dictive ability of the vascular parameters when they were added to
the traditional risk factors [24,25].We also assessed the IDI that did
not require a speciﬁc cut-off point for risk categories to determine
improvements in sensitivity and speciﬁcity [24].
All probability values presented are two-tailed, with statistical
signiﬁcance inferred at p<0.05. The statistical analyses were car-
ried out mainly using STATA 10.0 (StataCorp, College Station, TX,
USA).
Results
Comparisons of vascular parameters and traditional risk factors
between patients with and without coronary events
Seven patients were withdrawn from the study after enroll-
ment as they could no longer be contacted, and 10 patients were
excludedwhohadnon-cardiac death (7 due tomalignancy, 2 due to
respiratory diseases, and 1 due to an accident) during follow-up. A
total of923patients completed the follow-upstudy (1–102months,
mean 64±30 months). Coronary events occurred in 116 patients
during the follow-up period (29 patients with cardiac death, 46
patients with non-fatal MI, and 41 patients with unstable angina
requiring unplanned revascularization). The clinical characteristics
of the study patients with or without coronary events are summa-
rized in Table 1. Compared with patients without coronary events,
patients with coronary events were older, had higher LDL-C levels,
and higher prevalence of diabetes mellitus and multivessel CAD
(Table 1). Patients with coronary events had higher values of max-
IMTandbaPWVand lowerFMDthan thosewithout coronaryevents
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Table 1). Therewere no signiﬁcant differences in the types ofmed-
cation used between patients with and without coronary events
Table 1).
orrelation among FMD, baPWV, and maxIMT
As shown in Fig. 1, there was no signiﬁcant correlation between
MD and baPWV (r=−0.06, p=0.07). However, there was a signiﬁ-
ant correlationbetweenmaxIMTandbothFMD(r=−0.13,p=0.02)
nd baPWV (r=0.23, p=0.01).
redictive value of FMD, baPWV, and IMT in the prospective studyThe multivariate Cox proportional hazard analysis showed that
-SD increase in FMD (HR 0.50, 95% CI 0.38–0.66), 1-SD increase in
aPWV(HR1.52, 95%CI1.27–1.82), 1-SD increase inLDL-C (HR1.30,
5% CI 1.09–1.54), and number of diseased vessels (HR 1.92, 95% CI
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ig. 1. Correlation of baPWV with maxIMT (upper panel), FMD with maxIMT (mid-
le panel), and baPWV with FMD (lower panel). baPWV, brachial-ankle pulse
ave velocity; maxIMT, maximum intima-media thickness; FMD, ﬂow-mediated
ndothelium-dependent dilatation.diology 64 (2014) 179–184
1.30–2.85) were signiﬁcant predictors of future coronary events
(Table 2). maxIMT was signiﬁcant in the univariate Cox model, but
it did not remain signiﬁcant in the ﬁnal multivariate Cox model
(Table 2).
Incremental effect of the combination of vascular parameters on
the prediction of coronary events
The addition of either FMD or baPWV, alone or in combination,
had a signiﬁcant incremental effect on the areaunder theROCcurve
(AUC) that was generated using the traditional risk factors that we
determined at baseline (Table 3). Moreover, the AUC of our model
of the traditional risk factors was increased more by the addition
of the combination of FMD and baPWV than the addition of either
maxIMT, FMD, or baPWV alone, the combination of maxIMT and
FMD, or the combination of maxIMT and baPWV (Table 3). There
was no incremental effect of maxIMT alone on the AUC of the tradi-
tional risk factors, butmaxIMT in combinationwith FMDor baPWV
had an incremental effect on the AUC of the traditional risk factors
(Table 3). The NRI and IDI also showed that the addition of the
combination of FMD and baPWV had signiﬁcantly greater reclas-
siﬁcation and discrimination abilities compared with combination
of maxIMT and FMD or maxIMT and baPWV (Table 4).
Table 2
Univariate and multivariate Cox hazard analyses of the risk factors for future car-
diovascular events.
Univariate analysis Multivariate analysis
HR 95% CI HR 95% CI
Age (years) 1.28 1.05–1.56* 1.00 0.72–1.16
Male gender 1.21 0.80–1.83
Hypertension 1.15 0.78–1.67
Current smoking 1.1 0.70–1.50
Systolic BP 1.1 0.83–1.30
Diabetes mellitus 1.72 1.19–2.49* 1.42 0.97–2.08
LDL-C 1.30 1.09–1.53* 1.30 1.09–1.54*
HDL-C 0.83 0.68–1.01
CRP 1.14 0.99–1.29
Number of
diseased vessel
2.31 1.63–3.28* 1.92 1.30–2.85*
LVEF 0.94 0.78–1.12
maxIMT 1.34 1.13–1.58* 1.13 0.93–1.37
baPWV 1.53 1.32–1.78* 1.52 1.27–1.82*
FMD 0.43 0.32–0.58* 0.50 0.38–0.66*
The hazard ratios and 95% CI for continuous variables were estimated by a 1-SD
increase. BP, blood pressure; HDL-C, high-density lipoprotein cholesterol; LDL-C,
low-density lipoprotein cholesterol; CRP, C-reactive peptide; LVEF, left ventricular
ejection fraction; maxIMT, maximum intima-media thickness; baPWV, brachial-
ankle pulsewave velocity; FMD, ﬂow-mediated vasodilatation of the brachial artery.
* p<0.05.
Table 3
C-statistics for discriminationability of thevascular parameters in combinationwith
the traditional risk factors.
AUC p-value
vs. A vs. B vs. C vs. D vs. E vs. F
A, traditional risk factors 0.67 — — — — — —
B, A+maxIMT 0.67 0.91 — — — — —
C, A+ FMD 0.71 0.04 0.04 — — — —
D, A+baPWV 0.71 0.01 0.01 0.88 — — —
E, A+maxIMT+FMD 0.71 0.04 0.04 0.72 0.86 — —
F, A+maxIMT+baPWV 0.71 0.02 0.01 0.89 0.98 0.86 —
G, A+ FMD+baPWV 0.75 0.001 0.001 0.01 0.04 0.01 0.04
AUC, area under the receiver operating characteristic curve; maxIMT, maximum
intima-media thickness; baPWV, brachial-ankle pulse wave velocity; FMD, ﬂow-
mediated vasodilatation of the brachial artery. The traditional risk factors consisted
of age, male, systolic blood pressure, smoking, diabetes mellitus, low-density
lipoprotein cholesterol and the number of diseased vessels. All continuous variables
were estimated by a 1-SD increase.
W. Sugamata et al. / Journal of Car
Table 4
Discriminationabilityof thevascularparameters in combinationwith the traditional
risk factors.
Category-free NRI IDI
NRI value p IDI value p
Traditional risk factors
+maxIMT 0.21 0.04 0.001 0.28
+FMD 0.27 0.007 0.04 <0.0001
+baPWV 0.44 <0.0001 0.03 <0.0001
Traditional risks +maxIMT
+FMD 0.27 0.006 0.04 <0.0001
+baPWV 0.45 <0.0001 0.03 0.0001
Traditional risks +baPWV
+maxIMT 0.23 0.02 0.002 0.24
+FMD 0.29 0.003 0.04 <0.0001
Traditional risks + FMD
+baPWV 0.47 <0.0001 0.04 <0.0001
+maxIMT 0.11 0.24 0.0005 0.59
NRI, net reclassiﬁcation improvement; IDI, integrated discrimination improvement;
maxIMT, maximum intima-media thickness; baPWV, brachial-ankle pulse wave
velocity; FMD, ﬂow-mediated vasodilatation of the brachial artery. The traditional
r
l
c
D
i
w
w
ﬁ
a
A
o
F
m
T
i
c
e
ﬁ
o
[
i
r
t
a
m
b
c
s
T
m
e
o
o
l
v
e
t
a
h
b
v
eisk factors consisted of age, male, systolic blood pressure, smoking, diabetes mel-
itus, low-density lipoprotein cholesterol and the number of diseased vessels. All
ontinuous variables were estimated by a 1-SD increase.
iscussion
The present study demonstrated that FMD and baPWV were
ndependent predictors of secondary coronary events in patients
ith CAD after adjustment for covariates, which is in agreement
ith previous reports [1–5,8–12]. Furthermore, this study is the
rst to demonstrate that the addition of the combination of FMD
nd baPWV had a signiﬁcantly greater incremental effect on the
UC of the traditional risk factors.Moreover, the incremental effect
n the AUC was greater with the addition of the combination of
MD and baPWV than with the addition of either FMD, baPWV, or
axIMT alone or other combinations of the vascular parameters.
hus, the present ﬁndings indicate that FMDandbaPWVcontribute
ndependently and additionally to the predictability of secondary
oronary events in patients with chronic CAD.
In our patients with CAD, maxIMT was a predictor of coronary
vents in the univariate Cox model, but it was not signiﬁcant in the
nalmultivariate Coxmodel after adjustment for FMD, baPWV, and
ther covariates, which is in agreement with our previous study
9]. Moreover, maxIMT in combination with FMD or baPWV had an
ncremental effect on the predictive value of the traditional known
isk factors, whereas maxIMT alone did not. These results indicate
hat maxIMT may have low predictability in patients with CAD. In
ddition, the signiﬁcant correlation ofmaxIMTwith FMDor baPWV
ay partly account for the lower additive value of maxIMT in com-
ination with FMD or baPWV to predict events compared with
ombination of FMD and baPWV.
PWV reﬂects arterial stiffening that is increased by adverse
tructural and functional alterations in the vascular wall [4,5,21].
hese structural and functional abnormalities include an impair-
ent of endothelium-dependent dilation,medial hypertrophy, and
levated smoothmuscle tone that are associatedwithdevelopment
f atherosclerosis in the vascular tree [4,5,21]. The measurement
f baPWV is easy to perform and this parameter is closely corre-
ated with aortic PWV and carotid-femoral PWV, well-established
ascular tests for evaluation of arteriosclerosis and cardiovascular
vent risks [21,22]. FMD, amarker of endothelium-dependent dila-
ion, reﬂects endothelial function of the brachial artery [2,3,8,9],
nd maxIMT measures atherosclerotic plaque burden or medial
ypertrophy of the carotid artery [6,7,23]. The relationship of FMD,
aPWV, and maxIMT has been inconsistent among patients in pre-
ious studies [17–20]. This is partly because these arterial tests
valuate arteries at different sites, and arterial damage may notdiology 64 (2014) 179–184 183
necessarily develop uniformly throughout the arterial tree. In the
present study, FMDandbaPWVwerenot correlated; therefore, they
may evaluate different stages of arterial damage at the different
arterial sites in patients with CAD. Thus, FMD and baPWV may
provide complementary information about arterial structure and
function, and a combination of these vascular parameters might
be superior to any single vascular parameter alone for risk assess-
ment in CADpatients. Thismay account for the additive value of the
combination of FMDandbaPWV for the prediction of the secondary
coronary events.
In previous studies [1,4–7,10,11], these vascular parameters
could predict CV events in subjects or patients with relatively
low atherosclerotic risk proﬁles, but it was unclear whether they
also had a predictive value in patients with known cardiovascu-
lar disease and high atherosclerotic risk proﬁles. In this sense, the
present study clearly showed the utility of FMD and baPWV, alone
or in combination, as an adjunct to traditional risk factors for risk
assessment of secondary coronary events in patients with estab-
lished CAD and high-risk proﬁles.
This study had several limitations. First, the present study
included a relatively small number of patients with chronic CAD.
Thus, the usefulness of measurements of FMD and baPWV, alone
or in combination, for clinical practice could not be generalized in
other cohorts including patients with acute coronary syndrome.
Second, there is a possibility that maxIMT may have been underes-
timated in some patients due to technical and echogenic reasons.
Third, we could not perform PWV measurement in the morning
after overnight fast as performed in FMD measurement. It remains
unknown whether the intake of meal and increase in glucose level
affect the predictive values of baPWV in the present study; thus
other studies are needed to measure both baPWV and FMD under
conditions of overnight fast in all study patients. Fourth, we could
not determine the effects of anti-atherosclerotic therapies such as
anti-diabetic, lipid-lowering, and anti-hypertensive therapies on
vascular parameters, and whether these changes might inﬂuence
the prognostic values in this study population. Thus, a larger clin-
ical trial is needed to assess the changes of vascular parameters
after risk factor modiﬁcation and the predictive values of vascular
parameters in CAD patients.
In conclusion, the combined addition of FMD and baPWV to
the traditional risk factors signiﬁcantly increased the predictabil-
ity for the secondary coronary events compared with the addition
of either FMD, baPWV, or maxIMT alone or another combination
of these vascular parameters in patients with CAD. Thus, the com-
bined addition of FMD and baPWV in risk assessment algorithms
may be useful for risk stratiﬁcation in patients with stable CAD.
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